Showing results (1371-1380 of 1,689) with videos related to

Sort By:
Pageof 169
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 19, 2019
Management of patients with multidrug-resistant tuberculosisC Lange, R E Aarnoutse, J W C Alffenaar, et al.
Blood|August 28, 2024
Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analysesSikander Ailawadhi, Bertrand Arnulf, Krina Patel, et al.
Leukemia|August 12, 2020
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trialsLuciano J Costa, Benjamin A Derman, Susan Bal, et al.
Vascular Pharmacology|November 28, 2021
Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damageTiago J Costa, Simone R Potje, Thais F C Fraga-Silva, et al.
Transplantation and Cellular Therapy|December 9, 2022
Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN TrialsSaurabh Chhabra, Natalie Callander, Nicole L Watts, et al.
Blood Cancer Journal|April 22, 2024
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic riskNatalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, et al.
Bone Marrow Transplantation|August 4, 2015
A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphomaP Satwani, K W Ahn, J Carreras, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 29, 2013
Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant researchVikas Gupta, Adriana K Malone, Parameswaran N Hari, et al.
Blood|September 26, 2013
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBIEdward A Copelan, Betty K Hamilton, Belinda Avalos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 22, 2014
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiationEdward A Copelan, Belinda R Avalos, Kwang Woo Ahn, et al.
Pageof 169